prednisone has been researched along with Hypercholesterolemia in 39 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Hypercholesterolemia: A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To clarify the relative influences of cyclosporine (CsA) therapy, corticosteroid therapy, and other clinical variables on posttransplant hypercholesterolemia, total serum cholesterol levels were measured in 107 renal transplant recipients receiving one of three immunosuppression regimens: CsA and azathioprine (AZA) (group I); CsA, AZA, and prednisone (group II); or AZA and prednisone (group III)." | 7.68 | Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia. ( Hricik, DE; Mayes, JT; Schulak, JA, 1991) |
| "Prednisone was decreased from 5 mg/d to 2." | 5.30 | Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss. ( Bilir, B; Everson, GT; Kam, I; Karrer, F; Schroter, G; Shrestha, R; Stegall, MD; Sternberg, T; Wachs, M, 1997) |
| "An open-label, prospective, parallel study was performed in 20 cyclosporine-treated renal transplant recipients with hypercholesterolemia defined by a low-density lipoprotein (LDL) concentration greater than 160 mg/dL or a total cholesterol/high-density lipoprotein (HDL) concentration ratio greater than 5." | 3.69 | Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy. ( Austen, JL; Bartucci, MR; Hricik, DE; Knauss, TC; Schulak, JA; Shifrin, FA, 1996) |
| " Cyclosporine A plus steroid-based immuno-suppression regimens in these patients are associated with the development of hypertension, hyperlipidemia, obesity, and diabetes mellitus." | 3.69 | Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506). ( Canzanello, VJ; Krom, RA; Porayko, MK; Schwartz, L; Taler, SJ; Textor, SC; Wiesner, RH, 1997) |
| "To clarify the relative influences of cyclosporine (CsA) therapy, corticosteroid therapy, and other clinical variables on posttransplant hypercholesterolemia, total serum cholesterol levels were measured in 107 renal transplant recipients receiving one of three immunosuppression regimens: CsA and azathioprine (AZA) (group I); CsA, AZA, and prednisone (group II); or AZA and prednisone (group III)." | 3.68 | Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia. ( Hricik, DE; Mayes, JT; Schulak, JA, 1991) |
| " Dosing of these agents was concentration-controlled and open-labeled." | 2.71 | Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the Sirolimus European Renal Transplant Study. ( Bäckman, L; Brattström, C; Calne, R; Campistol, JM; Charpentier, B; Claesson, K; Durand, D; Groth, CG; Kreis, H; Lang, P; Morales, JM; Touraine, JL; Wramner, L, 2003) |
| " Long-term use of prednisone can give rise to multiple side effects and morbidity." | 2.68 | Late prednisone withdrawal in cyclosporine-treated kidney transplant patients: a randomized study. ( Hene, RJ; Hermans, J; Hollander, AA; van der Woude, FJ; van Es, LA, 1997) |
| "The Lovastatin treatment did not results in more adverse events than the placebo treatment." | 2.68 | [The effect of hypolipidemia treatment on the function of kidney transplanted from cadavers]. ( Bill, M; Durlik, M; Gaciong, Z; Gradowska, L; Juskowa, J; Lao, M; Paczek, L; Wyzgał, J, 1997) |
| "Atherogenic hypercholesteremia was found as frequently in patients on CyA as in those on Aza/P." | 2.66 | [Cyclosporin A and hyperlipidemia after kidney transplantation. Prospective study]. ( Brunner, FP; Hodel, K; Mordasini, RC; Thiel, G, 1986) |
| "Prednisone was decreased from 5 mg/d to 2." | 1.30 | Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss. ( Bilir, B; Everson, GT; Kam, I; Karrer, F; Schroter, G; Shrestha, R; Stegall, MD; Sternberg, T; Wachs, M, 1997) |
| "Hyperlipidemia is a common feature after organ transplantation." | 1.30 | Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study. ( Aranda, JL; de la Calle, A; del Palacio, A; Fernández-Miranda, C; Gómez-Izquierdo, T; Gómez-Sanz, R; Guijarro, C; Larumbe, S; Morales, JM; Moreno, E; Rodicio, JL, 1998) |
| "Hypercholesterolemia was defined as a fasting serum cholesterol level greater than 220 mg/dL." | 1.30 | Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy. ( Cantarell, C; Capdevila, L; Charco, R; Hidalgo, E; Lázaro, JL; Margarit, C; Murio, E; Vargas, V, 1999) |
| "These data suggest that long-term renal function in cyclosporine-treated kidney transplant patients is primarily influenced by the occurrence of early and late rejection episodes rather than by the dosage or duration of cyclosporine therapy." | 1.29 | Long-term renal function in cyclosporine-treated renal allograft recipients. ( Hodge, E; Novick, AC; Streem, S; Tanabe, K, 1995) |
| "The prevalence of hyperlipidemia in adolescents and young adults who are long-term survivors of pediatric renal transplantation with stable graft function has not previously been examined." | 1.29 | Hyperlipidemia in long-term survivors of pediatric renal transplantation. ( Hunninghake, DB; Kashtan, CE; Matas, AJ; Myers, TA; Sharma, AK, 1994) |
| " The most significant factor responsible for these metabolic complications was the total dosage of prednisone and cyclosporine." | 1.29 | Metabolic problems in recipients of liver transplants. ( Filo, RS; Hughes, D; Jindal, RM; Leapman, SB; Lumeng, L; Milgrom, ML; Pescovitz, MD; Sidner, RA, 1996) |
| "Although hypercholesterolemia is a frequent complication in cardiac transplant recipients, the exact mechanisms contributing to its development are not known." | 1.28 | Factors influencing the development of hypercholesterolemia after cardiac transplantation. ( Bolman, RM; Hertz, MI; Hunninghake, DB; Knutson, KR; Kubo, SH; Olivari, MT; Peters, JR, 1992) |
| "The severe hyperlipidemia in this patient was most likely induced by multiple interacting factors which included the metabolic abnormalities of nephrotic syndrome, steroid therapy, the underlying genetic predisposition of ApoE-2 homozygosity as well as diet and diuretic therapy." | 1.28 | Severe hyperlipidemia due to multiple factors in a child with nephrotic syndrome. ( Gregg, RE; Mann, WA; Ongkingco, JR; Ruley, EJ, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (23.08) | 18.7374 |
| 1990's | 17 (43.59) | 18.2507 |
| 2000's | 8 (20.51) | 29.6817 |
| 2010's | 4 (10.26) | 24.3611 |
| 2020's | 1 (2.56) | 2.80 |
| Authors | Studies |
|---|---|
| Breazzano, MP | 1 |
| Chen, RWS | 1 |
| Pugnet, G | 1 |
| Sailler, L | 1 |
| Bourrel, R | 1 |
| Montastruc, JL | 1 |
| Lapeyre-Mestre, M | 1 |
| Watad, A | 1 |
| Soriano, A | 1 |
| Vaknine, H | 1 |
| Shoenfeld, Y | 1 |
| Amital, H | 1 |
| Lally, L | 1 |
| Forbess, L | 1 |
| Hatzis, C | 1 |
| Spiera, R | 1 |
| Alama, JM | 1 |
| Justribó, MV | 1 |
| Illa, FB | 1 |
| Rivera Irigoín, R | 1 |
| Nicolau Ramis, J | 1 |
| Terrasa Sagrista, F | 1 |
| Masmiquel Comas, L | 1 |
| Charco, R | 2 |
| Bilbao, I | 1 |
| Chavez, R | 1 |
| Castells, LI | 1 |
| Hidalgo, E | 2 |
| Margarit, C | 2 |
| Charpentier, B | 1 |
| Groth, CG | 1 |
| Bäckman, L | 1 |
| Morales, JM | 2 |
| Calne, R | 1 |
| Kreis, H | 1 |
| Lang, P | 1 |
| Touraine, JL | 1 |
| Claesson, K | 1 |
| Campistol, JM | 1 |
| Durand, D | 1 |
| Wramner, L | 1 |
| Brattström, C | 1 |
| GIGUENS, W | 1 |
| GAROFALO, O | 1 |
| LORENZOYDEIBARRETA, J | 1 |
| TEMESIO, N | 1 |
| VILAVIDAL, P | 1 |
| SHEARN, MA | 1 |
| Muñoz Díaz, AB | 1 |
| Aguilar, P | 1 |
| McLaurin, EY | 1 |
| Holliday, SL | 1 |
| Williams, P | 1 |
| Brey, RL | 1 |
| Chang, A | 1 |
| Logar, CM | 1 |
| Finn, LS | 1 |
| Alpers, CE | 1 |
| Seliger, SL | 1 |
| Zhong, ZM | 1 |
| Yu, L | 1 |
| Weng, ZY | 1 |
| Hao, ZH | 1 |
| Zhang, L | 1 |
| Zhang, YX | 1 |
| Dong, WQ | 1 |
| Carlson, JA | 1 |
| Mazza, J | 1 |
| Kircher, K | 1 |
| Tran, TA | 1 |
| Aarnoudse, MW | 1 |
| Lamberts, HB | 1 |
| Dijk, F | 1 |
| Vos, J | 1 |
| de Vries, AJ | 1 |
| Castelao, AM | 1 |
| Grinyó, JM | 1 |
| Castiñeiras, MJ | 1 |
| Fiol, C | 1 |
| Gilvernet, S | 1 |
| Seron, D | 1 |
| Torras, J | 1 |
| Cruzado, JM | 1 |
| Alsina, J | 1 |
| Tanabe, K | 1 |
| Novick, AC | 1 |
| Streem, S | 1 |
| Hodge, E | 1 |
| Sharma, AK | 1 |
| Myers, TA | 1 |
| Hunninghake, DB | 2 |
| Matas, AJ | 1 |
| Kashtan, CE | 1 |
| Jindal, RM | 1 |
| Sidner, RA | 1 |
| Hughes, D | 1 |
| Pescovitz, MD | 1 |
| Leapman, SB | 1 |
| Milgrom, ML | 1 |
| Lumeng, L | 1 |
| Filo, RS | 1 |
| Austen, JL | 1 |
| Shifrin, FA | 1 |
| Bartucci, MR | 1 |
| Knauss, TC | 1 |
| Schulak, JA | 2 |
| Hricik, DE | 2 |
| Stegall, MD | 1 |
| Everson, GT | 1 |
| Schroter, G | 1 |
| Karrer, F | 1 |
| Bilir, B | 1 |
| Sternberg, T | 1 |
| Shrestha, R | 1 |
| Wachs, M | 1 |
| Kam, I | 1 |
| Hollander, AA | 1 |
| Hene, RJ | 1 |
| Hermans, J | 1 |
| van Es, LA | 1 |
| van der Woude, FJ | 1 |
| Paczek, L | 1 |
| Bill, M | 1 |
| Wyzgał, J | 1 |
| Gaciong, Z | 1 |
| Gradowska, L | 1 |
| Juskowa, J | 1 |
| Durlik, M | 1 |
| Lao, M | 1 |
| Canzanello, VJ | 1 |
| Schwartz, L | 1 |
| Taler, SJ | 1 |
| Textor, SC | 1 |
| Wiesner, RH | 1 |
| Porayko, MK | 1 |
| Krom, RA | 1 |
| Fernández-Miranda, C | 1 |
| de la Calle, A | 1 |
| Guijarro, C | 1 |
| Aranda, JL | 1 |
| Gómez-Sanz, R | 1 |
| Gómez-Izquierdo, T | 1 |
| Larumbe, S | 1 |
| Moreno, E | 1 |
| Rodicio, JL | 1 |
| del Palacio, A | 1 |
| Melchor, JL | 1 |
| Gracida, C | 1 |
| Rahman, P | 1 |
| Gladman, DD | 1 |
| Urowitz, MB | 1 |
| Yuen, K | 1 |
| Hallett, D | 1 |
| Bruce, IN | 1 |
| Cantarell, C | 1 |
| Vargas, V | 1 |
| Capdevila, L | 1 |
| Lázaro, JL | 1 |
| Murio, E | 1 |
| Ibels, LS | 1 |
| Alfrey, AC | 1 |
| Weil, R | 1 |
| Petri, M | 1 |
| Spence, D | 1 |
| Bone, LR | 1 |
| Hochberg, MC | 1 |
| Kubo, SH | 1 |
| Peters, JR | 1 |
| Knutson, KR | 1 |
| Hertz, MI | 1 |
| Olivari, MT | 1 |
| Bolman, RM | 1 |
| Ongkingco, JR | 1 |
| Mann, WA | 1 |
| Ruley, EJ | 1 |
| Gregg, RE | 1 |
| Mayes, JT | 1 |
| Stamler, JS | 1 |
| Vaughan, DE | 1 |
| Rudd, MA | 1 |
| Mudge, GH | 1 |
| Kirshenbaum, J | 1 |
| Young, P | 1 |
| Alexander, RW | 1 |
| Loscalzo, J | 1 |
| Hess, ML | 1 |
| Hastillo, A | 1 |
| Thompson, JA | 1 |
| Sansonetti, DJ | 1 |
| Szentpetery, S | 1 |
| Barnhart, G | 1 |
| Lower, RR | 1 |
| Hodel, K | 1 |
| Mordasini, RC | 1 |
| Brunner, FP | 1 |
| Thiel, G | 1 |
| Chiu, J | 1 |
| McLaine, PN | 1 |
| Drummond, KN | 1 |
| Scheitlin, W | 1 |
| Brunner, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multicenter Randomized Placebo Controlled Treatment Study of Leflunomide in Polymyalgia Rheumatica[NCT03576794] | Phase 3 | 94 participants (Anticipated) | Interventional | 2019-03-01 | Recruiting | ||
| CellCept (Mycophenolate Mofetil, MMF) Maintenance Immunosuppression in Liver Transplant Recipients With Long-term Follow-up Post-transplantation for Non-Autoimmune Liver Disease - A Prospective, Randomized, Multicenter Trial.[NCT00206076] | Phase 4 | 19 participants (Actual) | Interventional | 2006-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
assessed by liver biopsy using Banff International Consensus Schema (NCT00206076)
Timeframe: 12 months
| Intervention | participants (Number) |
|---|---|
| MMF, CNI Discontinued | 0 |
| MMF; CNI Decreased | 0 |
(NCT00206076)
Timeframe: 12 months
| Intervention | participants (Number) |
|---|---|
| MMF, CNI Discontinued | 2 |
| MMF; CNI Decreased | 1 |
(NCT00206076)
Timeframe: 12 months
| Intervention | participants (Number) |
|---|---|
| CNI Discontinued | 6 |
| CNI Reduction | 9 |
10 trials available for prednisone and Hypercholesterolemia
| Article | Year |
|---|---|
Brief Report: A Prospective Open-Label Phase IIa Trial of Tocilizumab in the Treatment of Polymyalgia Rheumatica.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Deprescriptions; Female; Glucocorticoids | 2016 |
Low incidence of hypercholesterolemia among liver transplant patients under tacrolimus monotherapy immunosuppression.
Topics: Adult; Drug Therapy, Combination; Follow-Up Studies; Graft Survival; Humans; Hypercholesterolemia; I | 2002 |
Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the Sirolimus European Renal Transplant Study.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclosporine; Drug Therapy, Combination; France; Graft Reject | 2003 |
[Therapeutic effect of Ginkgo biloba leaf extract on hypercholestrolemia in children with nephrotic syndrome].
Topics: Adolescent; Child; Child, Preschool; Dipyridamole; Drug Therapy, Combination; Female; Ginkgo biloba; | 2007 |
Effect of pravastatin in the treatment of hypercholesterolemia after renal transplantation under cyclosporine and prednisone.
Topics: Adult; Apolipoprotein A-I; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Drug Admin | 1995 |
Late prednisone withdrawal in cyclosporine-treated kidney transplant patients: a randomized study.
Topics: Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Hypercholeste | 1997 |
[The effect of hypolipidemia treatment on the function of kidney transplanted from cadavers].
Topics: Adult; Anticholesteremic Agents; Azathioprine; Cadaver; Cholesterol; Cholesterol, LDL; Creatinine; C | 1997 |
Treatment of hypercholesterolemia with fluvastatin in kidney transplant patients.
Topics: Adult; Anticholesteremic Agents; Azathioprine; Cholesterol; Cholesterol, LDL; Cyclosporine; Drug The | 1998 |
[Cyclosporin A and hyperlipidemia after kidney transplantation. Prospective study].
Topics: Adult; Azathioprine; Cyclosporins; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Immunosupp | 1986 |
A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood.
Topics: Adolescent; Alopecia; Child; Cyclophosphamide; Cystitis; Drug Synergism; Female; Humans; Hypercholes | 1973 |
29 other studies available for prednisone and Hypercholesterolemia
| Article | Year |
|---|---|
Scleritis With Uveal Effusion From Alirocumab.
Topics: Antibodies, Monoclonal, Humanized; Female; Glucocorticoids; Humans; Hypercholesterolemia; Middle Age | 2020 |
Is statin exposure associated with occurrence or better outcome in giant cell arteritis? Results from a French population-based study.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; France; Giant Cell Arteritis; Humans; Hyd | 2015 |
Immune Mediated Myopathy following Long-Term Statin Therapy.
Topics: Aged; Anti-Inflammatory Agents; Biopsy; Creatine Kinase; Electromyography; Female; Humans; Hydroxyme | 2015 |
[A new case of idiopathic bronchiolocentric interstitial pneumonia].
Topics: Animals; Animals, Domestic; Anti-Inflammatory Agents; Biopsy; Bird Fancier's Lung; Birds; Bronchiole | 2009 |
[Rosuvastatin-induced erythema multiforme].
Topics: Anti-Inflammatory Agents; Arthralgia; Drug Hypersensitivity; Drug Substitution; Emergencies; Erythem | 2013 |
[SYNDROME OF HEMOLYTIC ANEMIA WITH GLOBULAR FRAGMENTATION AND NEPHROPATHY].
Topics: Anemia, Hemolytic; Anti-Bacterial Agents; Erythrocytes; Heinz Bodies; Humans; Hypercholesterolemia; | 1963 |
NORMOCHOLESTEROLEMIC NEPHROTIC SYNDROME OF SYSTEMIC LUPUS ERYTHEMATOSUS.
Topics: Adolescent; Body Weight; Chloroquine; Cholesterol; Humans; Hypercholesterolemia; Lupus Erythematosus | 1964 |
[Idiopathic membranous nephropathy associated with anti-calcineurin toxicity. Prognosis and other immunosuppressive treatments].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcineurin Inhibitors; Ca | 2004 |
Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Aspirin; Autoant | 2005 |
A rare cause of necrotizing and crescentic glomerulonephritis in a young adult male.
Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Autoa | 2005 |
Otophyma: a case report and review of the literature of lymphedema (elephantiasis) of the ear.
Topics: Adrenal Cortex Hormones; Alcoholism; Anti-Infective Agents; Anti-Inflammatory Agents; Antidepressive | 2008 |
Monocytes and radiation-induced atheromatosis in rabbits.
Topics: Animals; Arteriosclerosis; Blood Cell Count; Carotid Arteries; Etoposide; Female; Hypercholesterolem | 1984 |
Long-term renal function in cyclosporine-treated renal allograft recipients.
Topics: Adult; Azathioprine; Chi-Square Distribution; Creatinine; Cyclosporine; Female; Graft Rejection; Hum | 1995 |
Hyperlipidemia in long-term survivors of pediatric renal transplantation.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Cholesterol; Cholesterol, HDL; Cohort Stud | 1994 |
Metabolic problems in recipients of liver transplants.
Topics: Adult; Azathioprine; Carbohydrate Metabolism; Creatinine; Cyclosporine; Diabetes Mellitus; Female; F | 1996 |
Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy.
Topics: Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Drug Therapy, Combinatio | 1996 |
Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss.
Topics: Adult; Aged; Diabetes Mellitus; Humans; Hypercholesterolemia; Hypertension; Liver Transplantation; M | 1997 |
Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506).
Topics: Adult; Benzothiadiazines; Blood Glucose; Blood Pressure; Body Weight; Cyclosporine; Diabetes Mellitu | 1997 |
Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study.
Topics: Adult; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Humans; Hypercholesterolemia; Hy | 1998 |
The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs.
Topics: Antimalarials; Antirheumatic Agents; Chloroquine; Cholesterol; Dose-Response Relationship, Drug; Dru | 1999 |
Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy.
Topics: Cholesterol; Cyclosporine; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Immunosuppressiv | 1999 |
Hyperlipidemia in adult, pediatric and diabetic renal transplant recipients.
Topics: Adolescent; Adult; Blood Glucose; Child; Cholesterol; Creatinine; Diabetes Complications; Drug Admin | 1978 |
Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices.
Topics: Adolescent; Adult; Baltimore; Cohort Studies; Coronary Disease; Cross-Sectional Studies; Female; Hos | 1992 |
Factors influencing the development of hypercholesterolemia after cardiac transplantation.
Topics: Adult; Blood Glucose; Cholesterol; Female; Heart Transplantation; Heart-Lung Transplantation; Humans | 1992 |
Severe hyperlipidemia due to multiple factors in a child with nephrotic syndrome.
Topics: Apolipoproteins E; Child, Preschool; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertri | 1991 |
Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia.
Topics: Adult; Azathioprine; Cholesterol; Cyclosporins; Drug Therapy, Combination; Female; Humans; Hyperchol | 1991 |
Frequency of hypercholesterolemia after cardiac transplantation.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Cyclosporins; Female; Heart Transplantation; Humans; Hype | 1988 |
Lipid mediators in organ transplantation: does cyclosporine accelerate coronary atherosclerosis?
Topics: Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Child; Coronary Disease; Cyclosporins; Female | 1987 |
[Follow-up studies of Zurich clinical cases].
Topics: Adult; Azathioprine; Cadaver; Chronic Disease; Follow-Up Studies; Glomerulonephritis; Hematologic Di | 1967 |